annb0t
Top 20
Veracyte VCYT delivered fourth-quarter 2024 earnings of 36 cents per share, which marked a stupendous improvement of 71.4% from the year-ago periodâs figure of 21 cents. The bottom line beat the Zacks Consensus Estimate by 24.1%.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The company-adjusted earnings per share (EPS) were 6 cents compared to the year-ago periodâs loss of 39 cents per share.
Full-year 2024 EPS of $1.19 increased 105.2% from the prior-ye...
>>> Read more: Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The company-adjusted earnings per share (EPS) were 6 cents compared to the year-ago periodâs loss of 39 cents per share.
Full-year 2024 EPS of $1.19 increased 105.2% from the prior-ye...
>>> Read more: Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
